B
BBRRF
vs
S&P 500
S&P 500
Over the past 12 months, BBRRF has outperformed S&P 500, delivering a return of +32% compared to the S&P 500's +13% growth.
Stocks Performance
BBRRF vs S&P 500
Performance Gap
BBRRF vs S&P 500
Performance By Year
BBRRF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Blueberries Medical Corp
Glance View
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.